Impact of Baseline Best-Corrected Visual Acuity on Outcomes with Aflibercept 8 mg in Patients with Diabetic Macular Edema.
- DOI
- 10.1016/j.oret.2026.03.018
- Published
- 2026-03-30
- Container
- Ophthalmol Retina
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.oret.2026.03.018,
title = {Impact of Baseline Best-Corrected Visual Acuity on Outcomes with Aflibercept 8 mg in Patients with Diabetic Macular Edema.},
author = {Javaheri M and Vakharia PS and Kaden TR and Adrean S and Ferrone PJ and Niu X and Maa J and Rastogi S and Patel D and Moini H and Reed K and Berliner AJ and Do DV.},
year = {2026},
journal = {Ophthalmol Retina},
doi = {10.1016/j.oret.2026.03.018},
url = {https://doi.org/10.1016/j.oret.2026.03.018}
}RIS
TY - JOUR TI - Impact of Baseline Best-Corrected Visual Acuity on Outcomes with Aflibercept 8 mg in Patients with Diabetic Macular Edema. AU - Javaheri M AU - Vakharia PS AU - Kaden TR AU - Adrean S AU - Ferrone PJ AU - Niu X AU - Maa J AU - Rastogi S AU - Patel D AU - Moini H AU - Reed K AU - Berliner AJ AU - Do DV. PY - 2026 JO - Ophthalmol Retina DO - 10.1016/j.oret.2026.03.018 UR - https://doi.org/10.1016/j.oret.2026.03.018 ER -
APA
M, J., PS, V., TR, K., S, A., PJ, F., X, N., J, M., S, R., D, P., H, M., K, R., AJ, B., & DV., D. (2026). Impact of Baseline Best-Corrected Visual Acuity on Outcomes with Aflibercept 8 mg in Patients with Diabetic Macular Edema.. Ophthalmol Retina. https://doi.org/10.1016/j.oret.2026.03.018
Source records
- europe-pmc · retrieved 2026-09-26T20:20:23.046Z